In-vivo and In-vitro Evidence of a Carrier-mediated Efflux Transport System for Oestrone-3-sulphate across the Blood-Cerebrospinal Fluid Barrier
- 1 March 2000
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 52 (3) , 281-288
- https://doi.org/10.1211/0022357001773968
Abstract
The efflux transport of oestrone-3-sulphate, a steroid hormone sulphate, across the blood-cerebrospinal fluid barrier has been examined following its intracerebroventricular administration. [3H]Oestrone-3-sulphate was eliminated from cerebrospinal fluid (CSF) with an apparent efflux clearance of 205 μL min−1 per rat. There was 25% of unmetabolized [3H]oestrone-3-sulphate in the plasma 5 min after intracerebroventricular administration, indicating that at least a part of [3H]oestrone-3-sulphate is transported from CSF to the circulating blood across the blood-CSF barrier. This efflux transport was inhibited by co-administration of excess oestrone-3-sulphate (25 mm 10 μL = 0.25 μmol) into rat cerebral ventricle. To characterize the oestrone-3-sulphate transport process, an in-vitro uptake experiment was performed using isolated rat choroid plexus. Oestrone-3-sulphate uptake by isolated rat choroid plexus was found to be a saturable process with a Michaelis-Menten constant (Km) of 18.1 ± 6.3 μm, and a maximum uptake rate (Vmax) of 48.0± 15.1 pmol min−1 μL−1 of tissue. The oestrone-3-sulphate transport process was temperature dependent and was inhibited by metabolic inhibitors such as 2,4-dinitrophenol and rotenone, suggesting an energy dependence. This uptake process was also inhibited by steroid hormone sulphates (1 mm dehydroepiandrosterone sulphate and 1 mm oestrone sulphate), bile acids (1 mm taurocholic acid and 1 mm cholic acid) and organic anions (1 mm sulphobromophthalein and 1 mm phenolsulphonphthalein), whereas 1 mm p-aminohippuric acid, 1 mm p-nitrophenol sulphate, 0.1 mm methotrexate and the cardiac glycoside, 2.5 μm digoxin, had little effect. In conclusion, these results provide evidence that oestrone-3-sulphate is transported from CSF to the circulating blood across the blood-CSF barrier via a carrier-mediated efflux transport system.Keywords
This publication has 21 references indexed in Scilit:
- Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2Published by Elsevier ,1998
- The choroid plexus epithelium is the site of the organic anion transport protein in the brainProceedings of the National Academy of Sciences, 1997
- Multispecific amphipathic substrate transport by an organic anion transporter of human liverJournal of Hepatology, 1996
- Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substratesAmerican Journal of Physiology-Renal Physiology, 1996
- Sinusoidal (Basolateral) Bile Salt Uptake Systems of HepatocytesSeminars in Liver Disease, 1996
- Expression cloning of a rat liver Na(+)-independent organic anion transporter.Proceedings of the National Academy of Sciences, 1994
- In vivo effects by estrone sulfate on the central nervous system-senile dementia (alzheimer's type)Journal of Steroid Biochemistry, 1989
- Regional distribution of arylsulfatase C and estrone-sulfate sulfatase activities in rat brain and hypophysisBrain Research, 1987
- Estrone sulphate in rat brain: uptake from blood and metabolism in vivo12Journal of Neurochemistry, 1973
- In vitro uptake of PAH- 3 H by choroid plexus from dogs of various agesAmerican Journal of Physiology-Legacy Content, 1972